ANNE M FAVRET M.D. NPI 1205803202

NPI Information

  • NPI: 1205803202
  • Provider Name: ANNE M FAVRET, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 8613 ROUTE 29 # 200N
    FAIRFAX, VA
    ZIP 22031
  • Phone: (571) 350-8400

Map and Directions

Get Directions

NPI Details

Anne M Favret, M.D. is a medical oncology internal medicine in Fairfax, VA with 33 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Anne M Favret, M.D. NPI is 1205803202. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1993

The provider's business location address is:

8613 ROUTE 29 # 200N
FAIRFAX, VA
ZIP 22031-171
Phone: (571) 350-8400
Fax: (703) 280-9596

The NPI 1205803202 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Uric acid level, blood (HCPCS:84550)
  • Protein measurement, serum (HCPCS:84165)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)

The enumeration date for this NPI number is 3/8/2006 and was last updated on 4/24/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology0101051630VIRGINIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1316256-266685OTHERVIRGINIAMAMSI/OP CHOICE/ALLIANCE
2541795091OTHERVIRGINIAFIRST HEALTH
3541795091OTHERVIRGINIATRICARE
41957580004OTHERVIRGINIACIGNA POS/PPO
5284764OTHERVIRGINIATRIGON/ANTHEM
61205803202MEDICAIDVIRGINIA
7541795091OTHERVIRGINIAFX CTY COMM HEALTH
8500617-2174366OTHERVIRGINIAAETNA HMO
9504732OTHERVIRGINIANCPPO
10541795091OTHERVIRGINIAPHCS PPO/POS
110870-0012OTHERVIRGINIABCBS NCA-CARE FIRST
123000039OTHERVIRGINIAUNITED HEALTHCARE
131957580004OTHERVIRGINIACIGNA HMO
14223802OTHERVIRGINIAKAISER
15500617-5801780OTHERVIRGINIAAETNA PPO

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.